Defective endogenous opioid response to exercise in type I diabetic patients

Metabolism: Clinical and Experimental

Volumn 45, Issue 2, 1996, Pages 137-142

  Wanke, T ^a   Auinger, M ^b   Formanek, D ^b   Merkle, M ^b   Lahrmann, H ^b   Ogris, E ^b   Zwick, H ^b   Irsigler, K ^b  

^a GENERAL HOSPITAL LINZ   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; OPIATE RECEPTOR;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; EXERCISE TOLERANCE; FEMALE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEUROTRANSMISSION; NOCICEPTION; PAIN THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STRESS; WORKLOAD;

EID: 0029930321     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90043-8     Document Type: Article

References (43)

1. Morley GK, Mooradian AD, Levine AS, et al: Mechanism of pain in diabetic peripheral neuropathy. Am J Med 77:79-82, 1984
2. Forman LJ, Estilow S, Lewis M, et al: Streptozocin diabetes alters immunoreactive β-endorphin levels and pain perception after 8 wk in female rats. Diabetes 35:1309-1313, 1986
3. Forman LJ, Estilow S, Mead J, et al: Eight weeks of streptozotocin-induced diabetes influences the effects of cold stress on immunoreactive beta-endorphin levels in female rats. Horm Metab Res 10:555-558, 1988
4. Ramabadran K, Bansinath M, Turndorf H, et al: The hyperalgesic effect of naloxone is attenuated in streptozotocin-diabetic mice. Psychopharmacology 97:169-174, 1989
5. Allen M: Activity-generated endorphins: A review of their role in sports science. Can J Appl Sport Sci 8:115-133, 1983
6. Schwarz L, Kindermann W: Changes in β-endorphin levels in response to aerobic and anaerobic exercise. Sports Med 13:25-36, 1992
7. Paulev PE, Thorboll JE, Nielsen U, et al: Opioid involvement in the perception of pain due to endurance exercise in trained man. Jpn J Physiol 39:67-74, 1989
8. Appenzeller O: What makes us run? N Engl J Med 305:578-579, 1981
9. Dearman J, Francis KT: Plasma levels of catecholamines, cortisol, and beta-endorphins in male athletes after running 26.2, 6, and 2 miles. J Sports Med 23:30-38, 1983
10. Dyck PJ: Detection, characterization and staging of polyneuropathy: Assessed in diabetics. Muscle Nerve 11:21-32, 1988
11. Wanke T, Abrahamian H, Lahrmann H, et al: No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM-patients. Diabetes 42:282-287, 1993
12. Killian KJ, Summers E, Campbell EJM: Dyspnea and leg effort during incremental cycle ergometry. Am Rev Respir Dis 145:1339-1345, 1992
13. Ruegemer JJ, Squires RW, Marsh HM, et al: Differences between prebreakfast and late afternoon glycemic responses to exercise in IDDM-patients. Diabetes Care 13:104-110, 1990
14. Jones NL: The interpretation of stage 1 exercise test results, in Jones NL (ed): Clinical Exercise Testing. Philadelphia, PA, Saunders, 1988, pp 158-185
15. Luger A, Deuster PA, Kyle SB, et al: Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. N Engl J Med 316:1309-1315, 1987
16. Quanjer PhD: Standardized lung function testing. Bull Eur Physiopathol Respir 19:1-95, 1983
17. Jones NL: Normal standards, in Jones NL (ed): Clinical Exercise Testing. Saunders, Philadelphia, PA, Saunders, 1988, pp 306-311
18. Allan EM, Green IC, Titheradge MA: The stimulation of glycogenolysis and gluconeogenesis in isolated hepatocytes by opioid peptides. Biochem J 216:507-510, 1983
19. Farrell PA, Sonne B, Mikines K, et al: Stimulatory role for endogenous opioid peptides on postexercise insulin secretion in rats. J Appl Physiol 65:744-749, 1988
20. Jonal MN, Colt EWD, Clarke WC, et al: Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: Effects of naloxone. Pain 19:13-25, 1984
21. Surbey GD, Andrew GM, Cervenko FW, et al: The effect of naloxone on the performance of intense exercise. Med Sci Sport Exerc 15:150, 1983 (abstr)
22. Grossmann A, Bouloux P, Price P, et al: The role of opioid peptides in the hormonal responses to acute exercise in man. Clin Sci 67:483-491, 1984
23. Carr D, Bullen B, Skrinar G, et al: Physical conditioning facilitates the exercise-induced secretion of beta-endorphin and beta-lipotropin in women. N Engl J Med 305:560-563, 1981
24. Moretti C, Fabbri A, Gnessi L, et al: Naloxone inhibits exercise-induced release of PRL and GH in athletes. Clin Endocrinol (Oxf) 18:135-138, 1983
25. Rossier J, French ED, Rivier C, et al: Foot shock induced stress increases β-endorphin levels in blood but not in the brain. Nature 270:618-620, 1977
26. Santiago TV, Edelman NH: Opioids and breathing. J Appl Physiol 59:1675-1685, 1985
27. Rapaport SI, Klee KD, Pettigren KD, et al: Entry of opioid peptides into the central nervous system. Science 207:84-86, 1979
28. Carr DB, Jones KJ, Bergland RM, et al: Causal links between plasma and CSF endorphin levels in stress: Vector-ARMA analysis. Peptides 6:5-10, 1985 (suppl 1)
29. Gerner RH, Sharp B, Catlin DH: Peripherally administered β-endorphin increases cerebrospinal fluid endorphin immunoreactivity. J Clin Endocrinol Metab 55:358-360, 1982
30. Madden J, Akil H, Patrick RL, et al: Stress induced parallel changes in central opioid levels and pain responsiveness in the rat. Nature 265:358-360, 1977
31. Osgood PF, Murphy JL, Carr DB, et al: Increases in plasma beta-endorphin and tail flick latency in the rat following burn injury. Life Sci 40:547-554, 1987
32. Petrozzino JJ, Scardella AT, Santiago TV, et al: Dichlor-acetate blocks endogenous opioid effects during inspiratory flowresistive loading. J Appl Physiol 72:590-596, 1992
33. Goldfarb AH, Hatfield BD, Armstrong D, et al: Plasma beta-endorphin concentration: Response to intensity and duration of exercise. Med Sci Sports Exerc 22:241-244, 1990
34. Simon GS, Dewey WL: Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine. J Pharmacol Exp Ther 218:318-323, 1981
35. Timmers K, Vogles NR, Zalenski C, et al: Altered β-endorphin, met- and leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome. Diabetes 35:1143-1151, 1986
36. Solerte SB, Fioravanti M, Petraglia F, et al: Plasma β-endorphin, free fatty acids and blood lipid changes in type 2 (non-insulin dependent) diabetic patients. J Endocrinol Invest 11:37-428, 1988
37. Solerte SB, Fioravanti M, Petraglia F, et al: Circulating opioids and plasma renin activity in insulin-dependent diabetics with renal haemodynamic alterations. Nephron 46:194-198, 1987
38. McCall AL: The impact of diabetes on the CNS. Diabetes 41:557-570, 1992
39. Dandona P, James IM, Newburg PA, et al: Cerebral blood flow in diabetes mellitus: Evidence of abnormal cerebrovascular reactivity. Br Med J 2:325-326, 1978
40. Weiss ST: Pulmonary function as a phenotype physiologic marker of cardiovasular morbidity and mortality. Chest 99:265-266, 1991
41. Ramires PR, Forjaz CLM, Silva MER, et al: Exercise tolerance is lower in type 1 diabetics compared with normal young men. Metabolism 42:191-195, 1993
42. Kremser CB, Levitt NS, Borow KM, et al: Oxygen uptake kinetics during exercise in diabetic neuropathy. J Appl Physiol 65:2665-2671, 1988
43. Falcone C, Specchia G, Rondanelli R, et al: Correlation between beta-endorphin plasma levels and anginal symptoms in patients with coronary artery disease. J Am Coll Cardiol 11:719-723, 1988